
浏览全部资源
扫码关注微信
收稿:2019-06-26,
纸质出版:2019-12-15
移动端阅览
傅洪, Victor W. Xia. 术前β受体阻滞剂对肝移植术中循环管理及术后短期心肌损伤和脑卒中的影响:一项倾向评分匹配研究[J]. 第三军医大学学报, 2019,41(23):2355-2360.
Hong FU, W. Xia Victor. Effects of preoperative beta blockers on intraoperative circulation management and short-term myocardial injury and stroke after liver transplantation: a propensity-matched study[J]. Journal of Third Military Medical University, 2019, 41(23): 2355-2360.
傅洪, Victor W. Xia. 术前β受体阻滞剂对肝移植术中循环管理及术后短期心肌损伤和脑卒中的影响:一项倾向评分匹配研究[J]. 第三军医大学学报, 2019,41(23):2355-2360. DOI: 10.16016/j.1000-5404.201906220.
Hong FU, W. Xia Victor. Effects of preoperative beta blockers on intraoperative circulation management and short-term myocardial injury and stroke after liver transplantation: a propensity-matched study[J]. Journal of Third Military Medical University, 2019, 41(23): 2355-2360. DOI: 10.16016/j.1000-5404.201906220.
Objective
2
To retrospectively analyze the effect of preoperative use of β-blockers on blood transfusion volume
use of pressor drugs
post-reperfusion syndrome
and incidence of heart muscle injury and stroke within 30 d after operation during liver transplantation (LT) by a propensity-matched study.
Methods
2
A retrospective study was performed on the patients who underwent LT at UCLA Ronald Reagan medical center between October 2005 and September 2014 after the approval of the Institutional Review Board of the university (IRB#11-003058). According to the preoperative use of β-blockers or not
these patients were divided into β-blockers group (
n
=643) and non β-blockers group (
n
=809). The difference of preoperative variables between the 2 groups was analyzed by single factor analysis. The variables with a value of
P
<
0.05 and those of important relevant clinical status were selected in a logistic regression model to generate a propensity score for each patient. The patients in 2 groups were matched in 1: 1 with the nearest propensity scores. The amount of blood transfusion
use of vasopressors
incidence of post-reperfusion syndrome
and occurrence of myocardial injury and stroke within 30 d after LT were compared between the 2 groups.
Results
2
Based on the clinical data of 2 102 patients recruited in this study
single factor analysis showed that the patients of the β-blocker
group were significantly older
larger proportion of males
and higher incidences of hypertension
coronary artery disease
diabetes
and gastrointestinal bleeding. The results of logistic regression analysis eliminated after propensity match (442 patients in each group
totally 884 patients) indicated that there were no significant differences in the amount of intraoperative blood transfusion (18.8±16.1
vs
20.3±18.0 U
P
=0.155)
administration of vasopressors (77.4%
vs
79.0%
P
=0.556)
incidence of post-reperfusion syndrome (14.7%
vs
14.9%
P
=0.901)
and occurrence of myocardial injury (3.8%
vs
4.3%
P
=0.761) and stroke (0.7%
vs
2.0%
P
=0.143) within 30 d after LT between the 2 matched groups.
Conclusion
2
Preoperative use of β-blockers for over 7 d has no effect on amount of blood transfusion
use of vasopressors
incidence of post-reperfusion syndrome
and occurrence of myocardial injury and stroke within 30 d after LT. The drug can be continuously administered for the patients with end-stage liver disease before undergoing LT.
BLESSBERGER H KAMMLER J STEINWENDER C Perioperative use of β-blockers in cardiac and noncardiac surgery JAMA 2015 313 20 2070 2071 10.1001/jama.2015.1883 BLESSBERGER H, KAMMLER J, STEINWENDER C. Perioperative use of β-blockers in cardiac and noncardiac surgery[J]. JAMA, 2015, 313(20): 2070-2071. DOI:10.1001/jama.2015.1883.
SWEDBERG K Can beta-blockers be used safely in non-cardiac surgery? Important lessons to be learned Eur Heart J 2017 38 31 2429 2430 10.1093/eurheartj/ehx291 SWEDBERG K. Can beta-blockers be used safely in non-cardiac surgery? Important lessons to be learned[J]. Eur Heart J, 2017, 38(31): 2429-2430. DOI:10.1093/eurheartj/ehx291.
FLEISHER L A FLEISCHMANN K E AUERBACH A D 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines J Am Coll Cardiol 2014 64 22 e77 e137 10.1016/j.jacc.2014.07.944 FLEISHER L A, FLEISCHMANN K E, AUERBACH A D, et al . 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines[J ] . J Am Coll Cardiol, 2014, 64(22): e77-e137. DOI:10.1016 /j.jacc.2014.07.944.
SANFILIPPO F SANTONOCITO C FOËX P Use of beta-blockers in non-cardiac surgery: an open debate Minerva Anestesiol 2014 80 4 482 494 http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1177/0148607102026001011 SANFILIPPO F, SANTONOCITO C, FOËX P. Use of beta-blockers in non-cardiac surgery: an open debate[J]. Minerva Anestesiol, 2014, 80(4): 482-494.
BOSCH J MASTI R KRAVETZ D Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis Hepatology 1984 4 6 1200 1205 10.1002/hep.1840040617 BOSCH J, MASTI R, KRAVETZ D, et al . Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis[J ] . Hepatology, 1984, 4(6): 1200-1205. DOI:10.1002/hep.1840040617.
GARCIA-TSAO G BOSCH J Management of varices and variceal hemorrhage in cirrhosis N Engl J Med 2010 362 9 823 832 10.1056/NEJMra0901512 GARCIA-TSAO G, BOSCH J. Management of varices and variceal hemorrhage in cirrhosis[J]. N Engl J Med, 2010, 362(9): 823-832. DOI:10.1056/NEJMra0901512.
QURESHI W MITTAL C AHMAD U Clinical predictors of post-liver transplant new-onset heart failure Liver Transpl 2013 19 7 701 710 10.1002/lt.23654 QURESHI W, MITTAL C, AHMAD U, et al . Clinical predictors of post-liver transplant new-onset heart failure[J ] . Liver Transpl, 2013, 19(7): 701-710. DOI:10.1002/lt.23654.
SAFADI A HOMSI M MASKOUN W Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery Circulation 2009 120 13 1189 1194 10.1161/CIRCULATIONAHA.108.847178 SAFADI A, HOMSI M, MASKOUN W, et al . Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery[J ] . Circulation, 2009, 120(13): 1189-1194. DOI:10.1161/CIRCULATIONAHA.108.847178.
JUPITER D C Propensity score matching: retrospective randomization? J Foot Ankle Surg 2017 56 2 417 420 10.1053/j.jfas.2017.01.013 JUPITER D C. Propensity score matching: retrospective randomization?[J]. J Foot Ankle Surg, 2017, 56(2): 417-420. DOI:10.1053/j.jfas.2017.01.013.
HAJIBANDEH S HAJIBANDEH S ANTONIOU S A Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis Br J Anaesth 2017 118 1 11 21 10.1093/bja/aew380 HAJIBAND EH S, HAJIBANDEH S, ANTONIOU S A, et al . Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis[J ] . Br J Anaesth, 2017, 118(1): 11-21. DOI:10.1093/bja/aew380.
TOBIN S W HASHEMI S DADSON K Heart failure and MEF2 transcriptome dynamics in response to β-blockers Sci Rep 2017 7 1 4476 10.1038/s41598-017-04762-x TOBIN S W, HASHEMI S, DADSON K, et al . Heart failure and MEF2 transcriptome dynamics in response to β-blockers[J ] . Sci Rep, 2017, 7(1): 4476. DOI:10.1038/s41598-017-04762-x.
WIJEYSUNDERA D N DUNCAN D NKONDE-PRICE C Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines Circulation 2014 130 24 2246 2264 10.1161/CIR.0000000000000104 WIJEYSUNDERA D N, DUNCAN D, NKONDE-PRICE C, et al . Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines[J ] . Circulation, 2014, 130(24): 2246-2264. DOI:10.1161/CIR.00000000 00000104.
AMR Y M AMIN S M Effects of preoperative β-blocker on blood loss and blood transfusion during spinal surgeries with sodium nitroprusside-controlled hypotension Saudi J Anaesth 2012 6 3 263 267 10.4103/1658-354X.101219 AMR Y M, AMIN S M. Effects of preoperative β-blocker on blood loss and blood transfusion during spinal surgeries with sodium nitroprusside-controlled hypotension[J]. Saudi J Anaesth, 2012, 6(3): 263-267. DOI:10.4103/1658-354X.101219.
SINISCALCHI A GAMBERINI L BARDI T Post-reperfusion syndrome during orthotopic liver transplantation, which definition best predicts postoperative graft failure and recipient mortality? J Crit Care 2017 41 156 160 10.1016/j.jcrc.2017.05.020 SINISCALCHI A, GAMBERINI L, BARDI T, et al . Post-reperfusion syndrome during orthotopic liver transplantation, which definition best predicts postoperative graft failure and recipient mortality?[J ] . J Crit Care, 2017, 41: 156-160. DOI:10.1016/j.jcrc.2017.05.020.
KORK F RIMEK A ANDERT A Visual quality assessment of the liver graft by the transplanting surgeon predicts postreperfusion syndrome after liver transplantation: a retrospective cohort study BMC Anesthesiol 2018 18 1 29 10.1186/s12871-018-0493-9 KORK F, RIMEK A, ANDERT A, et al . Visual quality assessment of the liver graft by the transplanting surgeon predicts postreperfusion syndrome after liver transplantation: a retrospective cohort study[J ] . BMC Anesthesiol, 2018, 18(1): 29. DOI:10.1186/s12871-018-0493-9.
FORD R M BOOK W SPIVEY J R Liver disease related to the heart Transplant Rev (Orlando) 2015 29 1 33 37 10.1016/j.trre.2014.11.003 FORD R M, BOOK W, SPIVEY J R. Liver disease related to the heart[J]. Transplant Rev (Orlando), 2015, 29(1): 33-37. DOI:10.1016/j.trre.2014.11.003.
ZARDI E M ZARDI D M CHIN D Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase J Cardiol 2016 67 2 125 130 10.1016/j.jjcc.2015.04.016 ZARDI E M, ZARDI D M, CHIN D, et al . Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase[J ] . J Cardiol, 2016, 67(2): 125-130. DOI:10.1016/j.jjcc.2015.04.016.
NICOLAU-RADUCU R GITMAN M GANIER D Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients Liver Transpl 2015 21 1 13 21 10.1002/lt.23997 NICOLAU-RADUCU R, GITMAN M, GANIER D, et al . Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients[J ] . Liver Transpl, 2015, 21(1): 13-21. DOI:10.1002/lt.23997.
WESSELINK E M KAPPEN T H TORN H M Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review Br J Anaesth 2018 121 4 706 721 10.1016/j.bja.2018.04.036 WESSELINK E M, KAPPEN T H, TORN H M, et al . Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review[J ] . Br J Anaesth, 2018, 121(4): 706-721. DOI:10.1016/j.bja.2018.04.036.
WIJEYSUNDERA D N BEATTIE W S WIJEYSUNDERA H C Duration of preoperative β-blockade and outcomes after major elective noncardiac surgery Can J Cardiol 2014 30 2 217 223 10.1016/j.cjca.2013.10.011 WIJEYSUNDERA D N, BEATTIE W S, WIJEYSUNDERA H C, et al . Duration of preoperative β-blockade and outcomes after major elective noncardiac surgery[J ] . Can J Cardiol, 2014, 30(2): 217-223. DOI:10.1016/j.cjca.2013.10.011.
FLU W J VAN KUIJK J P CHONCHOL M Timing of pre-operative Beta-blocker treatment in vascular surgery patients: influence on post-operative outcome J Am Coll Cardiol 2010 56 23 1922 1929 10.1016/j.jacc.2010.05.056 FLU W J, VAN KUIJK J P, CHONCHOL M, et al . Timing of pre-operative Beta-blocker treatment in vascular surgery patients: influence on post-operative outcome[J ] . J Am Coll Cardiol, 2010, 56(23): 1922-1929. DOI:10.1016/j.jacc.2010.05.056.
SERSTÉ T FRANCOZ C DURAND F Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study J Hepatol 2011 55 4 794 799 10.1016/j.jhep.2011.01.034 SERSTÉ T, FRANCOZ C, DURAND F, et al . Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study[J ] . J Hepatol, 2011, 55(4): 794-799. DOI:10.1016/j.jhep.2011.01.034.
GE P S RUNYON B A When should the β-blocker window in cirrhosis close? Gastroenterology 2014 146 7 1597 1599 10.1053/j.gastro.2014.04.028 GE P S, RUNYON B A. When should the β-blocker window in cirrhosis close?[J]. Gastroenterology, 2014, 146(7): 1597-1599. DOI:10.1053/j.gastro.2014.04.028.
AUSTIN P C MAMDANI M M STUKEL T A The use of the propensity score for estimating treatment effects: administrative versus clinical data Stat Med 2005 24 10 1563 1578 10.1002/sim.2053 AUSTIN P C, MAMDANI M M, STUKEL T A, et al . The use of the propensity score for estimating treatment effects: administrative versus clinical data[J ] . Stat Med, 2005, 24(10): 1563-1578. DOI:10.1002/sim.2053.
AUSTIN P C GROOTENDORST P ANDERSON G M A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study Stat Med 2007 26 4 734 753 10.1002/sim.2580 AUSTIN P C, GROOTENDORST P, ANDERSON G M. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study[J]. Stat Med, 2007, 26(4): 734-753. DOI:10.1002/sim.2580.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621